PTP4A3 and cancer: Pediatric patients with tumor expression of PRL3 more frequently displayed negative prognostic clinical characteristics; PRL3-expressing pediatric tumors also showed overexpression of angiogenic factors and cancer-associated kinases implicated in other PRL3-positive cancers.